<p>Invo Fertility Inc. 宣布与单一机构投资者达成 400 万美元的私募配售。该公司将发行 2,366,864 股普通股（或预先融资的认股权证），并附带认股权证，允许购买最多 4,733,728 股普通股，所有股份的综合价格为每股 1.69 美元。认股权证将在股东批准后生效，并将在五年后到期。这些证券以私募方式提供，未根据证券法注册。Invo Fertility 已同意提交注册声明以便转售这些证券。Maxim Group LLC 是本交易的唯一配售代理。预计此次发行的毛收益约为 400 万美元，未扣除费用和支出。免责声明：本新闻简报由公共技术公司（PUBT）使用生成性人工智能创建。虽然 PUBT 努力提供准确和及时的信息，但此 AI 生成的内容仅供参考，不应被解读为财务、投资或法律建议。Invo Fertility Inc. 于 2025 年 12 月 02 日发布了用于生成本新闻简报的原始内容，并对此信息承担全部责任。© 版权 2025 - 公共技术公司（PUBT）原始文档：这里</p>

<p>INVO Fertility Inc. 宣布与一位机构投资者达成 400 万美元的私募配售，发行 2,366,864 股普通股和 4,733,728 股的认股权证，价格为每股 1.69 美元。认股权证在获得股东批准后可行使，有效期为五年。Maxim Group LLC 是唯一的配售代理。预计在扣除费用和支出之前，毛收益将达到 400 万美元</p>

<p>Invo Fertility Inc. has announced a $4.0 million private placement with a single institutional investor. The company will issue 2,366,864 shares of common stock (or pre-funded warrants) along with warrants to purchase up to 4,733,728 shares of common stock, all at a combined price of $1.69 per share. The warrants will become exercisable upon shareholder approval and will expire five years from that date. The securities are being offered in a private placement and have not been registered under the Securities Act. Invo Fertility has agreed to file a registration statement for the resale of these securities. Maxim Group LLC is acting as the sole placement agent for the transaction. Gross proceeds from the offering are expected to be approximately $4.0 million before fees and expenses. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Invo Fertility Inc. published the original content used to generate this news brief on December 02, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>
<div class="lb-trans"><p>Invo Fertility Inc. 宣布与单一机构投资者达成 400 万美元的私募配售。该公司将发行 2,366,864 股普通股（或预先融资的认股权证），并附带认股权证，允许购买最多 4,733,728 股普通股，所有股份的综合价格为每股 1.69 美元。认股权证将在股东批准后生效，并将在五年后到期。这些证券以私募方式提供，未根据证券法注册。Invo Fertility 已同意提交注册声明以便转售这些证券。Maxim Group LLC 是本交易的唯一配售代理。预计此次发行的毛收益约为 400 万美元，未扣除费用和支出。免责声明：本新闻简报由公共技术公司（PUBT）使用生成性人工智能创建。虽然 PUBT 努力提供准确和及时的信息，但此 AI 生成的内容仅供参考，不应被解读为财务、投资或法律建议。Invo Fertility Inc. 于 2025 年 12 月 02 日发布了用于生成本新闻简报的原始内容，并对此信息承担全部责任。© 版权 2025 - 公共技术公司（PUBT）原始文档：这里</p>
</div>

INVO Fertility 通过私募筹集了 400 万美元